How Mitchell Ng and his Thessalus Capital crew target healthy returns. Meet the ivy league students behind a healthcare fund that's currently beating the S&P 500 and promises to deliver more.
Source: International Business Times UK
Moderna claims Pfizer and its German partner infringed patents in developing their COVID vaccine
Moderna Inc. on Friday filed lawsuits against Pfizer Inc. and German partner BioNTech SE, alleging the pair infringed patents relating to its mRNA platform, a key technology behind all of their COVID vaccines.
In 2018, Rishi Bagaria was promoted from analyst to junior partner and director at Thessalus Capital...
Even though biotech markets are “down big this year,” Managing Director Mitchell Ng of Thessalus Capital says that there are “specific industries within the healthcare sector that are very promising,” such as gene editing companies. Yahoo Finance’s Alexis Christoforous speaks to him about the future for biotech in 2019.
Source: Yahoo Finance
CRISPR, (Clustered Regularly Interspaced Short Palindromic Repeats), is a technology that allows scientists to edit genes in living cells.
Bloomberg Markets with Carol Massar and Jason Kelly. Mitchell Ng, Managing Director at Thessalus Capital, is a 23-year old medical student who also invests in biotech. He discusses why he likes TG Therapeutics, aming others.
It holds vast applications, from curing genetic diseases, detecting and treating cancers, treating HIV by blocking replication in human cells, bioengineering new crops and plants, eliminating malaria, to editing DNA in live human embryos.
Starting a hedge fund and making millions remains one of the most glamorized paths to fame and fortune in America. It's the tried and true storyline in Hollywood hits from Wolf of Wall Street and The Big Short.
As an industry, healthcare is exploding and is an increasingly interesting space for investors.
Investing in healthcare poses a unique challenge. Healthcare is enormously complex, only rewarding fund managers with deep technical understanding of scientific and regulatory developments within the industry.
It’s the classic rags to riches story. Start off with a small loan from friends and family, invest it in the market, and make millions, if not billions.
Source: Huffington Post
Thessalus Capital Management, a student-run investment fund based in Princeton, NJ, beat the odds in 2015. In a year of flatline markets, with the S&P 500 returning 1.4% and the average Wall Street hedge fund posting -3%, Thessalus notched a +7% gain after incorporation in September.
Source: Yahoo Finance
student-run hedge fund, Thessalus Capital Management, gained 4.6% in Q1 with equity investments mainly in healthcare.
Source: HFM Week
Mitchell Ng ’16 and Edward Xiao ’16 founded a student-run investment fund that currently manages $150,000 in assets.
Source: The Daily Princetonian